NNOX News and Press, NANO-X IMAGING LTD From 06/06/22

Gainers:  Yumanity Therapeutics YMTX +46%. Babylon (BBLN) +11%. Sema4 (SMFR) +11%. Nano-X Imaging (NNOX) +10%. Satsuma Pharmaceuticals (STSA) +10%. Losers: Praxis Precision Medicines PRAX -63%. eFFECTOR Therapeutics (EFTR) -20%. Pear Therapeutics (PEAR) ...

Image source: The Motley Fool. Nano-X Imaging Ltd. (NASDAQ: NNOX) Q1 2022 Earnings Call May 19, 2022 , 8:30 a.m. ET Operator Continue reading For further details see: Nano-X Imaging Ltd. (NNOX) Q1 2022 Earnings Call Transcript

Nano-X Imaging Ltd (NNOX) Q1 2022 Earnings Conference Call May 19, 2022 8:30 AM ET Company Participants Mike Cavanaugh - IR, ICR Westwicke Erez Meltzer - Chief Executive Officer Ran Daniel - Chief Financial Officer Conference Call Participants Suraj Kalia - Oppenheimer Jeffrey Cohen - Ladenbr...

Nano-X Imaging (NASDAQ:NNOX), an Israel-based developer of medical imaging technology, has lost ~8% in the pre-market Thursday after the company reported lower than expected revenue with its 1Q 2022 financials. During its first full quarter of revenue generation, Nano-X (NNOX) repor...

Nano-X Imaging press release (NASDAQ:NNOX): Q1 Revenue of $1.81M (+38% Q/Q). Non-GAAP gross profit of $ 0.7 million for the three months ended March 31, 2022, which represents a gross profit margin of approximately 39% on a non-GAAP basis. As of March 31, 2022, the Company had $73.7M of cash,...

Reports progress towards global supply chain development Ended the first quarter of 2022 with cash and marketable securities of $139.5 million Management to host conference call and webcast today, May 19, 2022 at 8:30 AM ET NANO-X IMAGING LTD (NASDAQ: NNOX) (...

NANO-X IMAGING LTD (" Nanox " or the " Company ," Nasdaq: NNOX) will report its results for the first quarter ended March 31, 2022 before market on Thursday, May 19, 2022. Erez Meltzer, Chief Executive Officer, and Ran Daniel, Chief Financial Officer, will host a conference call...

NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2021 with the U.S. Securities and Exchange Commission (“SECȁ...

Nano-X Imaging (NASDAQ:NNOX) on Thursday said its unit Nanox.AI got a U.S. Food and Drug Administration (FDA) premarket medical device clearance for its HealthOST device, an AI software that provides clinicians with a spinal analysis to help in the treatment of musculoskeletal disease, such a...

HealthOST is a fully automated spinal analysis of vertebral compression fractures and low bone density often associated with osteoporosis NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announced that i...